XML 31 R71.htm IDEA: XBRL DOCUMENT v2.4.0.8
Derivative Financial Instruments - Total Notional or Contractual Amounts, Fair Value, Collateral and Net Exposure of Derivative Financial Instruments (Detail) (USD $)
In Thousands, unless otherwise specified
Sep. 30, 2014
Dec. 31, 2013
Derivative [Line Items]    
Fair Value $ 101,182 $ 113,101
Net Exposure 94,552 [1] 108,021
Collateral 6,630 [2] 5,080
Derivatives designated as hedging instruments | Interest rate risks | Interest rate swaps | Other assets
   
Derivative [Line Items]    
Notional or Contractual Amount 45,964 45,964
Fair Value 4,965 6,492
Net Exposure 1,055 [1] 1,412
Collateral 3,910 [2] 5,080
Derivatives not designated as hedging instruments | Currency exchange risks
   
Derivative [Line Items]    
Fair Value 645 789
Net Exposure (1,290) [1] 789
Collateral 1,935 [2] 0
Derivatives not designated as hedging instruments | Currency exchange risks | Foreign exchange forwards | Other assets
   
Derivative [Line Items]    
Notional or Contractual Amount 33,840 140,760
Fair Value 1,032 1,423
Net Exposure (903) [1] 1,423
Collateral 1,935 [2] 0
Derivatives not designated as hedging instruments | Currency exchange risks | Foreign exchange forwards | Other liability
   
Derivative [Line Items]    
Notional or Contractual Amount 30,306 62,649
Fair Value (387) (634)
Net Exposure (387) [1] (634)
Collateral 0 [2] 0
Derivatives not designated as hedging instruments | Other derivative instruments | Equity warrant assets | Other assets
   
Derivative [Line Items]    
Notional or Contractual Amount 186,853 179,934
Fair Value 94,960 103,513
Net Exposure 94,960 [1] 103,513
Collateral 0 [2] 0
Derivatives not designated as hedging instruments | Other derivative instruments | Other derivatives
   
Derivative [Line Items]    
Fair Value 612 2,307
Net Exposure (173) [1] 2,307
Collateral 785 [2] 0
Derivatives not designated as hedging instruments | Other derivative instruments | Other derivatives | Foreign exchange forwards | Other assets
   
Derivative [Line Items]    
Notional or Contractual Amount 526,329 424,983
Fair Value 16,111 13,673
Net Exposure 15,326 [1] 13,673
Collateral 785 [2] 0
Derivatives not designated as hedging instruments | Other derivative instruments | Other derivatives | Foreign exchange forwards | Other liability
   
Derivative [Line Items]    
Notional or Contractual Amount 483,262 367,079
Fair Value (15,355) (11,549)
Net Exposure (15,355) [1] (11,549)
Collateral 0 [2] 0
Derivatives not designated as hedging instruments | Other derivative instruments | Other derivatives | Client foreign currency options | Other assets
   
Derivative [Line Items]    
Notional or Contractual Amount 6,500 91,854
Fair Value 91 434
Net Exposure 91 [1] 434
Collateral 0 [2] 0
Derivatives not designated as hedging instruments | Other derivative instruments | Other derivatives | Client foreign currency options | Other liability
   
Derivative [Line Items]    
Notional or Contractual Amount 6,500 91,854
Fair Value (91) (434)
Net Exposure (91) [1] (434)
Collateral 0 [2] 0
Derivatives not designated as hedging instruments | Other derivative instruments | Other derivatives | Loan conversion options | Other assets
   
Derivative [Line Items]    
Notional or Contractual Amount 1,442 3,455
Fair Value 0 314
Net Exposure 0 [1] 314
Collateral 0 [2] 0
Derivatives not designated as hedging instruments | Other derivative instruments | Other derivatives | Client interest rate derivatives | Other assets
   
Derivative [Line Items]    
Notional or Contractual Amount 359,074 216,773
Fair Value 2,173 1,265
Net Exposure 2,173 [1] 1,265
Collateral 0 [2] 0
Derivatives not designated as hedging instruments | Other derivative instruments | Other derivatives | Client interest rate derivatives | Other liability
   
Derivative [Line Items]    
Notional or Contractual Amount 359,074 216,773
Fair Value (2,317) (1,396)
Net Exposure (2,317) [1] (1,396)
Collateral $ 0 [2] $ 0
[1] Net exposure for contracts in a gain position reflects the replacement cost in the event of nonperformance by all such counterparties. The credit ratings of our institutional counterparties as of September 30, 2014 remain at investment grade or higher and there were no material changes in their credit ratings during the three and nine months ended September 30, 2014.
[2] Cash collateral received from our counterparties in relation to market value exposures of derivative contracts in our favor is recorded as a component of “short-term borrowings” on our consolidated balance sheets.